Vera Therapeutics, Inc. (VERA) ownership: Avoro Capital Advisors LLC 24% · institutions 117% · index and ETF funds 5% (13F 2026-06-30). Insider activity, 90 days: Routine (13 sales, 0 open-market buys). SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| BlackRock | 5747760.00 | $246.64M | 8.0% | 2026-06-30 |
| Avoro Capital Advisors LLC | 5723888.00 | $245.61M | 8.0% | 2026-06-30 |
| State Street | 4148786.00 | $178.02M | 5.8% | 2026-06-30 |
| Price T Rowe Associates Inc | 4012936.00 | $172.20M | 5.6% | 2026-06-30 |
| Deep Track Capital, LP | 4000000.00 | $171.64M | 5.6% | 2026-06-30 |
| Vanguard | 3930924.00 | $168.68M | 5.5% | 2026-06-30 |
| Deerfield Management Company, L.P. | 3916400.00 | $168.05M | 5.5% | 2026-06-30 |
| Kynam Capital Management, LP | 2890059.00 | $124.01M | 4.0% | 2026-06-30 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-09-02 | |
| Sell | null | 2026-09-02 | |
| Sell | null | 2026-09-02 | |
| Sell | null | 2026-08-03 | |
| Sell | null | 2026-08-03 | |
| Sell | null | 2026-07-07 | |
| Sell | null | 2026-07-07 | |
| Sell | null | 2026-07-07 |
Back to VERA overview · VERA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.